Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 20 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. causal interaction 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. diagnostic usage 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. therapeutic application 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. ongoing research 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. diagnostic usage 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. ongoing research 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. unassigned 0
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Carcinoma 8910032 Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland. diagnostic usage 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Carcinoma 8910032 Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland. ongoing research 1
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Carcinoma 8910032 Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland. unassigned 0
Results 1 - 10 of 20 > >>